Navigation Links
DIA And FDA To Host Two Important Critical Path Workshops

The Drug Information Association (DIA) and the Food and Drug Administration (FDA) will host the Critical Path Initiative (CPI) on the Move: Complexities and Challenges (September 15 -16; Bethesda, MD) and the Critical Path Transporter Workshop (October 2-3; North Bethesda, MD).

Horsham, PA (PRWEB) July 25, 2005-- The [Drug Information Association (DIA)] and the Food and Drug Administration (FDA) will host the [Critical Path Initiative (CPI) on the Move: Complexities and Challenges] (September 15 -16; Bethesda, MD) and the [Critical Path Transporter Workshop] (October 2-3; North Bethesda, MD).

"The FDA Critical Path Initiative is a key FDA science-based effort to modernize the science and tools used in the development, evaluation, manufacture, and use of all FDA-regulated products, explains Program Co-chair Rachel E. Behrman, MD, MPH, Director, Office of Critical Path Programs, OC, FDA. "This workshop will explore what has been accomplished, current projects and their status, and future opportunities."

The [Critical Path Initiative (CPI) on the Move: Complexities and Challenges] will feature speakers/panelists such as Janet Woodcock, MD, Director, Center for Drug Evaluation and Research, FDA; Mark B. McClellan, MD, PhD, Chair, Reagan-Udall Foundation and Director, Engelberg Center for Health Care Reform Brookings; and Raymond Woosley, MD, PhD, President and CEO, Critical Path Institute.

The [Critical Path Transporter Workshop] will be held in collaboration with PhRMA, the American Association of Pharmaceutical Scientists, and International Society for the Study of Xenobiotics.

"Leading scientists from academia, the FDA, and industry will present and lead discussion on the current status of the rapidly emerging field of drug transporters, the clinical relevance of drug uptake and efflux transporters, and the application of in vitro and in vivo tools to drug discovery and development," notes Program Committee Member Shiew-Mei Huang, PhD, FCP, Deputy Director, Office of Clinical Pharmacology, CDER, FDA.

Featured sessions will include:

  • Focus on key transporters
  • Current and future technical challenges
  • Drug development and FDA examples

In March 2004, FDA first announced the Critical Path Initiative, which was designed to identify additional mechanisms through applied scientific studies to develop better methods and new technologies that may improve the product development process. Since that time, a number of efforts have launched to leverage collaborations to modernize development of new genomic, imaging, statistical, methodological, analytical, and informatics tools, with the ultimate goal of reducing the uncertainty about product performance throughout the medical product life cycle.

About the [Drug Information Association (DIA)]
The Drug Information Association serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit or call 215-442-6100.


Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
2. New class of RNA molecules may be important in human cancer
3. UVA researchers find important clue to immune infertility
4. Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill
5. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
6. Daytime, Nighttime Blood Pressure Both Important
7. Schwarzenegger Signs Bill to Remove Written Informed Consent for HIV Testing; "Most Important Change in Public HIV/AIDS Policy in Years," Says AHF
8. Video: Holiday Safety Is Important
9. Quality of life: most important predictor of survival for advanced NSCLC patients
10. Research highlights important indicators of early-stage ovarian cancer
11. The most important candidate genes for pancreatic stone formation
Post Your Comments:
(Date:11/25/2015)... ... ... Many people know of the common symptoms of low thyroid hormone (also ... many people who find their cholesterol levels and weight are creeping up are more ... they don’t have any of the other symptoms. , Thyroid hormone plays a major ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has focused on providing comprehensive solutions involving adult stem cell therapies to patients ... officially deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... lower prices in an early celebration of the early holiday shopping season. Starting ... $29.95 each (normally $33.95 ea). Black Friday promotional pricing is in addition to ...
(Date:11/24/2015)... ... November 24, 2015 , ... Eric C. Seidel, DMD ... benefits of the revolutionary BIOLASE WaterLase iPlus 2.0™ system. This advanced laser technology ... by a dentist in Gettysburg, PA . From routine visits to cosmetic ...
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now visit ... ON practice. Dr. Williams has been providing dental service for over 34 years, and ... can lead to a variety of complications if they are not replaced quickly, including ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Calif. , Nov. 24, 2015 /PRNewswire/ ... leader in non-invasive genetic testing and the ... that it will present at the 27 ... York on Wednesday, December 2, 2015 at 1:00 p.m. ET.  Matthew Rabinowitz, ... Company,s financial results, business activities and financial ...
(Date:11/24/2015)... 24, 2015  In the pharmaceutical industry, companies want ... to quickly uncover new insights, tactics and strategies that ... --> However, organizations often find it ... and ensure that all rules and regulations are met ... major barrier to efficiently launching market research projects is ...
(Date:11/24/2015)... , Nueva York , 24 ... Devices (ABD), fabricante del Avery Breathing Pacemaker System, ... Jonzon , MD; Ph.D. como consultor clínico. ...   --> Foto - ... El doctor Jonzon es un fisiólogo y ...
Breaking Medicine Technology: